#CNBC Mizuho’s Jared Holz on how to play the underperforming health care sector
Mizuho’s Jared Holz on how to play the underperforming health care sector
Jared Holz, Mizuho Securities healthcare sector strategist, joins ‘The Exchange’ to discuss Insmed’s lung drug being greenlit by the FDA and his read on the healthcare sector.
Thank you for your support in keeping this website running.💛
View on “Tokyo Trend News”
#MILENIO
コメントを送信